Project Grant HT94252410401
Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $820K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
- The University of Chicago will receive $2,624,000 through a Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of amino acid metabolism in pulmonary fibrosis. Through this award, the University of Chicago aims to advance understanding of medical solutions for pulmonary disorders and translate findings into improved patient...
- The University of Chicago was awarded a $1,306,778 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA". This 4-year grant, beginning on August 1, 2025, will support the university's advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project...
- The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
- The University of Chicago was awarded a $2,624,000.00 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to fund the research project "TARGETING TISSUE-RESIDENT ALVEOLAR MACROPHAGE METABOLISM IN ACUTE LUNG INJURY". This four-year grant, running from April 1, 2024 to March 31, 2028, supports cutting-edge biomedical research aimed at improving health outcomes for military service members, veterans, and their families. The research...
- This Project Grant award of $869,193 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF) at the University of Chicago. The project aims to advance scientific understanding and develop potential medical solutions relevant to military personnel and the broader public. The grant has a performance period from July 1, 2025 to June 30, 2028. The University of...
- This federal Project Grant award of $1,612,104.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Chicago to develop senescent tumor cell-loaded dendritic cell vaccines for breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The 3-year...
- The University of Chicago was awarded a $574,000 Project Grant from the Defense Health Agency to support a research project titled "A HUMAN PLURIPOTENT STEM CELL-BASED APPROACH TO IDENTIFYING THE DRIVERS OF PULMONARY CARCINOID". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research. The project, spanning from September 1, 2023 to...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
- The University of Chicago was awarded a $1,032,525 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support the development of digital pathology biomarkers for breast cancer recurrence scoring through September 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will further...
- This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $3,085,852.00 to the University of Chicago to develop novel claudin-2 channel blockers for the treatment of inflammatory bowel disease. The 4-year project, starting on Jul 1, 2024 and ending on Jun 30, 2028, aims to advance the research and development of new therapeutic approaches for this debilitating condition. As a leading...